Benchmark agrees £16m sale of vaccine facility Aquaculture health, genetics and nutrition company Benchmark Holdings has agreed to sell its vaccine manufacturing facility in Braintree, Essex for £16 million as part of a £100m government plan to accelerate the mass production of a successful Covid-19 vaccine.
Vaccine expert joins HIPRA’s push into aquaculture Veterinary pharma firm HIPRA is strengthening its presence in aquaculture and the salmon market by recruiting Bjarte Lygren as Regional Technical & Marketing Manager Aqua.
Vaccine sales dip Vaccine sales to salmon in Norway declined by just under 2% in 2016, falling to 328.1 million doses, down from 332.6 million the year before, according to the latest figures released by Pharmaq.
